A leading medical technology company in London, known for its pioneering approaches, has secured a significant £4 million investment. This funding aims to revolutionise dental treatment solutions in the UK.
Evo, a company spearheaded by Dr R.P. Vijayanarayanan, is renowned for its rapid full jaw dental reconstructions, integrating cutting-edge technology akin to aerospace engineering. The recent investment will propel Evo’s growth, expanding its reach across the UK and exploring international markets.
BGF’s commitment to advancing healthcare innovation is evident in its portfolio of investments. Backing companies like Evo demonstrates its dedication to enhancing healthcare delivery and supporting groundbreaking technologies.
With the new investment, Evo is set to scale unprecedented heights in dental technology and patient care. The company’s vision for future growth, supported by BGF, signals a transformative era in the healthcare sector.
Evo’s story exemplifies how innovative engineering and patient-centred approaches can create impactful solutions in medical technology, poised to benefit countless patients both nationally and globally.
